Diabetes
-
Breakthrough drug from Eli Lilly shows remarkable weight loss in obesity treatment
USA — An experimental drug developed by Eli Lilly has demonstrated unprecedented success in helping patients with obesity shed an average of 24% of their…
-
Insulet launches Omnipod 5 automated insulin delivery system in the UK, expanding global access
UNITED KINGDOM — Insulet Corp. has announced the commercial launch of its Omnipod 5 Automated Insulin Delivery (AID) System in the United Kingdom. This tubeless…
-
China takes the lead in revolutionizing Diabetes treatment with world’s first oral insulin: GlobalData
CHINA —China is on the verge of a groundbreaking achievement in the field of diabetes treatment, as Hefei Tianhui Biotechnology Co. Ltd. (HTIT) has submitted…
-
Medtronic expands Its diabetes care portfolio with acquisition of EOFlow
IRELAND —Global healthcare technology company Medtronic has announced its definitive agreement to acquire EOFlow, a South Korea-based medical device company in a significant move to…
-
Guidepost introduces AI-powered chatbot to enhance diabetes management in South Africa
SOUTH AFRICA — Guidepost, a South African health tech company, has successfully completed its trial period and is now launching an artificial intelligence (AI)-powered chatbot…
-
Novo Nordisk to limit supply of initial doses of Wegovy to cope with high demand
USA — Danish pharmaceutical company, Novo Nordisk, has announced that it will limit the supply of starter doses of weight-loss medication Wegovy as the demand…
-
Eli Lilly raises profit guidance after success with diabetes treatment
USA — Eli Lilly, a multinational pharmaceutical company, has recently exceeded its first-quarter sales estimates and consequently raised its annual revenue and profit forecasts. The…
-
FDA gives green light to Medtronic’s insulin pump with meal detection tech
USA — The U.S. Food and Drug Administration (FDA) has approved Medtronic’s new insulin pump with meal detection technology, the MiniMed 780G system, for patients…
-
Lilly’s weight-loss drug Mounjaro to be pitted against Wegovy in upcoming study
USA — Pharmaceutical company Eli Lilly has registered a phase 3b clinical trial on clinicaltrials.gov for its weight loss drug, Mounjaro. The study, known as…
-
Aspect and Novo Nordisk team up to develop diabetes and obesity treatment in US$75M deal
DENMARK —Novo Nordisk, a global healthcare company specializing in diabetes care, has joined forces with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and…